US 12,115,383 B2
Brain stimulation treatment in depression
Amit Etkin, Stanford, CA (US); Corey Keller, Palo Alto, CA (US); and Wei Wu, Palo Alto, CA (US)
Assigned to THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY, Palo Alto, CA (US); and THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS, Washington, DC (US)
Filed by The Board of Trustees of the Leland Stanford Junior University, Stanford, CA (US); and The United States Government as Represented by the Department of Veterans Affairs, Washington, DC (US)
Filed on Mar. 24, 2022, as Appl. No. 17/703,639.
Application 17/703,639 is a continuation of application No. 16/095,661, granted, now 11,324,963, previously published as PCT/US2017/029687, filed on Apr. 26, 2017.
Claims priority of provisional application 62/459,814, filed on Feb. 16, 2017.
Claims priority of provisional application 62/328,719, filed on Apr. 28, 2016.
Prior Publication US 2022/0280801 A1, Sep. 8, 2022
Int. Cl. A61N 2/00 (2006.01); A61B 5/00 (2006.01); A61B 5/246 (2021.01); A61B 5/372 (2021.01); A61N 1/36 (2006.01); A61N 2/02 (2006.01)
CPC A61N 2/006 (2013.01) [A61B 5/0075 (2013.01); A61B 5/246 (2021.01); A61B 5/372 (2021.01); A61N 1/36025 (2013.01); A61N 2/02 (2013.01)] 22 Claims
OG exemplary drawing
 
1. A method for treating depression, the method comprising:
measuring an electrical response of a brain of a subject having depression and detecting a presence of intracortical inhibition; and
administering a transcranial magnetic stimulation (TMS) therapy to the subject having depression and intracortical inhibition, wherein the TMS therapy reduces the intracortical inhibition, thereby treating depression.